BEIJING, Jan. 10, 2012 /PRNewswire-Asia-FirstCall/ --
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier" or
the "Company"), an emerging leader in the development, assembly,
marketing and sale of medical devices and homecare medical
products, today announced that it has received Conformite
Europeenne (CE) certification for its sleep diagnostic devices and
air compressors.
(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO
)
Dehaier's DHR-998 sleep diagnostic device collects data on
patients' respiration flow, pulse, oximetry, thoracoabdominal
breathing, snoring and body position. Dehaier's air compressors are
key supplemental devices for medical ventilators. The CE mark
recognizes that the two products meet European Union (EU) health
and safety standards and are approved for sale in the 27 member
states of the EU and in the four members of the European Free Trade
Association (EFTA).
Mr. Ping Chen, Chairman and Chief
Executive Officer of Dehaier Medical stated, "We are thrilled to
obtain the CE marking, which validates the high quality and
manufacturing standards of Dehaier's innovative medical products.
This lays a strong foundation for us to offer our sleep diagnostic
devices and air compressors in the EU markets. Moreover, we intend
to leverage this approval to further expand our distribution
network in the European Union as well as other markets that rely on
the CE mark process."
"We already ship our air compressor products to the Czech Republic, Hungary, Kyrgyzstan, Pakistan, Ukraine, and the
Philippines. Following the CE approval, we will continue to
seek more distribution and OEM opportunities worldwide," said Ms.
Rayna Dong, Director of Dehaier's
International Marketing. "The CE marking strengthens our ability to
cooperate with potential distributors from EU countries. In the
near term, we look to establish a strong footprint in the European
market, which presents an enormous potential for Dehaier's medical
equipment and homecare products."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy),
Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent
Medical (US) and JMS (Japan).
Dehaier's technology is based on five patents and five software
copyrights; additionally Dehaier has three pending patents, six
pending software copyrights and proprietary technology. More
information may be found at http://www.chinadhr.com.
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular statements about Dehaier's international growth plans
and prospects(such as any plans to expand into European markets),
future acceptance of its products in China and abroad, receipt of regulatory
approvals for Dehaier's products, the impact of receipt of such
approvals on business prospects and results of relationships with
distributors. These statements are subject to uncertainties and
risks including, but not limited to, product and service demand and
acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, future
developments in payment for and demand for medical equipment and
services, implementation of and performance under the joint venture
agreement by all parties, and other risks contained in reports
filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and
whether made by or on behalf of the company, are expressly
qualified by the cautionary statements and any other cautionary
statements which may accompany the forward-looking statements. In
addition, the company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after
the date hereof.
Contact Us
Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Lisa Zhou
+86 10-5166-0080
zhouyj@dehaier.com.cn
SOURCE Dehaier Medical Systems Ltd.